Literature DB >> 24654754

A feminizing adrenocortical carcinoma in the context of a late onset 21-hydroxylase deficiency.

Rossella Libé1, Wiebke Arlt, Estelle Louiset, Charlotte Waintrop, Jean Guibourdenche, Mathilde Sibony, Eric Clauser, Lionel Groussin.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 24654754     DOI: 10.1210/jc.2014-1342

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  6 in total

Review 1.  5th International ACC Symposium: Old Syndromes with New Biomarkers and New Therapies with Old Medications.

Authors:  Sarika N Rao; Mouhammed Amir Habra
Journal:  Horm Cancer       Date:  2015-12-10       Impact factor: 3.869

Review 2.  The way toward adulthood for females with nonclassic congenital adrenal hyperplasia.

Authors:  Georgia Ntali; Sokratis Charisis; Christo F Kylafi; Evangelia Vogiatzi; Lina Michala
Journal:  Endocrine       Date:  2021-04-14       Impact factor: 3.633

Review 3.  Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome.

Authors:  Henrik Falhammar; Anna Nordenström
Journal:  Endocrine       Date:  2015-06-17       Impact factor: 3.633

Review 4.  Feminizing adrenocortical tumors: Literature review.

Authors:  Farida Chentli; Ilyes Bekkaye; Said Azzoug
Journal:  Indian J Endocrinol Metab       Date:  2015 May-Jun

Review 5.  Non-Classical Congenital Adrenal Hyperplasia in Childhood.

Authors:  Selim Kurtoğlu; Nihal Hatipoğlu
Journal:  J Clin Res Pediatr Endocrinol       Date:  2016-06-29

6.  Late onset adrenal insufficiency after adrenalectomy due to latent nonclassical 21-hydroxylase deficiency: A case report.

Authors:  Hiroyuki Hirai; Keisuke Kuwana; Yoshiro Kusano
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.